Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy

BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. METHODS—All patients were administered intravenous alteplase with/wi...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 48; no. 6; pp. 1548 - 1553
Main Authors Batchelor, Connor, Pordeli, Pooneh, d’Esterre, Christopher D., Najm, Mohamed, Al-Ajlan, Fahad S., Boesen, Mari E., McDougall, Connor, Hur, Lisa, Fainardi, Enrico, Shankar, Jai Jai Shiva, Rubiera, Marta, Khaw, Alexander V., Hill, Michael D., Demchuk, Andrew M., Sajobi, Tolulope T., Goyal, Mayank, Lee, Ting-Yim, Aviv, Richard I., Menon, Bijoy K.
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.06.2017
Subjects
Online AccessGet full text
ISSN0039-2499
1524-4628
1524-4628
DOI10.1161/STROKEAHA.117.016616

Cover

Abstract BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. METHODS—All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case–control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min ·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). RESULTS—One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63–0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). CONCLUSIONS—Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.
AbstractList Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication.BACKGROUND AND PURPOSEIntracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication.All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status).METHODSAll patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status).One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6).RESULTSOne-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6).Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.CONCLUSIONSBaseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.
Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case-control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min·per 100 g, relative volume of T ≥16 s with all volumes standardized to axis coverage, mean permeability surface area product values within T ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade ( <0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume ( =0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63-0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.
BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal computed tomography in predicting this complication. METHODS—All patients were administered intravenous alteplase with/without intra-arterial therapy. An age- and sex-matched case–control design with classic and conditional logistic regression techniques was chosen for analyses. Outcome was parenchymal hemorrhage on 24- to 48-hour imaging. Exposure variables were imaging (noncontrast computed tomography hypoattenuation degree, relative volume of very low cerebral blood volume, relative volume of cerebral blood flow ≤7 mL/min ·per 100 g, relative volume of Tmax ≥16 s with all volumes standardized to z axis coverage, mean permeability surface area product values within Tmax ≥8 s volume, and mean permeability surface area product values within ipsilesional hemisphere) and clinical variables (NIHSS [National Institutes of Health Stroke Scale], onset to imaging time, baseline systolic blood pressure, blood glucose, serum creatinine, treatment type, and reperfusion status). RESULTS—One-hundred eighteen subjects (22 patients with parenchymal hemorrhage versus 96 without, median baseline NIHSS score of 15) were included in the final analysis. In multivariable regression, noncontrast computed tomography hypoattenuation grade (P<0.006) and computerized tomography perfusion white matter relative volume of very low cerebral blood volume (P=0.04) were the only significant variables associated with parenchymal hemorrhage on follow-up imaging (area under the curve, 0.73; 95% confidence interval, 0.63–0.83). Interrater reliability for noncontrast computed tomography hypoattenuation grade was moderate (κ=0.6). CONCLUSIONS—Baseline hypoattenuation on noncontrast computed tomography and very low cerebral blood volume on computerized tomography perfusion are associated with development of parenchymal hemorrhage in patients with acute ischemic stroke receiving intravenous alteplase.
Author McDougall, Connor
d’Esterre, Christopher D.
Fainardi, Enrico
Shankar, Jai Jai Shiva
Sajobi, Tolulope T.
Menon, Bijoy K.
Najm, Mohamed
Demchuk, Andrew M.
Boesen, Mari E.
Hur, Lisa
Goyal, Mayank
Aviv, Richard I.
Rubiera, Marta
Lee, Ting-Yim
Pordeli, Pooneh
Khaw, Alexander V.
Batchelor, Connor
Al-Ajlan, Fahad S.
Hill, Michael D.
AuthorAffiliation From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Departme
AuthorAffiliation_xml – name: From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Department of Clinical Neurosciences, University of Western Ontario (A.V.K.); Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia (F.S.A.-A.); and Department of Neurology, Neuroradiology, Dalhousie University, Halifax, Nova Scotia (J.J.S.S.)
Author_xml – sequence: 1
  givenname: Connor
  surname: Batchelor
  fullname: Batchelor, Connor
  organization: From the Calgary Stroke Program, Department of Clinical Neurosciences (P.P., C.D.d., M.N., F.S.A.-A., C.M., L.H., M.D.H., A.M.D., T.T.S., M.G., B.K.M.), Department of Radiology (C.D.d., M.D.H., A.M.D., M.G., T.-Y.L., B.K.M.), Department of Community Health Sciences (P.P., M.D.H., T.T.S., B.K.M.), and Biomedical Engineering Graduate Program (M.E.B.), University of Calgary, Alberta; Hotchkiss Brain Institute, Calgary, Alberta (P.P., M.D.H., A.M.D., T.T.S., M.G., B.K.M.); Seaman Family Research Centre, Foothills Medical Centre, Calgary, Alberta (C.B., C.D.d., M.N., M.E.B., L.H., M.D.H., A.M.D., M.G., B.K.M.); Department of Neuroradiology, Sunnybrook Health Sciences Centre, University of Toronto, Ontario (R.I.A.); Department of Diagnostic Imaging, University Hospital, Florence, Italy (E.F.); Department of Neurology, Hospital Vall d’Hebron, Ps. Vall d’Hebron, Barcelona, Spain (M.R.); Lawson Health Research Institute and Robarts Research Institute, London, Ontario (A.V.K., T.-Y.L.); Department of Clinical Neurosciences, University of Western Ontario (A.V.K.); Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia (F.S.A.-A.); and Department of Neurology, Neuroradiology, Dalhousie University, Halifax, Nova Scotia (J.J.S.S.)
– sequence: 2
  givenname: Pooneh
  surname: Pordeli
  fullname: Pordeli, Pooneh
– sequence: 3
  givenname: Christopher
  surname: d’Esterre
  middlename: D.
  fullname: d’Esterre, Christopher D.
– sequence: 4
  givenname: Mohamed
  surname: Najm
  fullname: Najm, Mohamed
– sequence: 5
  givenname: Fahad
  surname: Al-Ajlan
  middlename: S.
  fullname: Al-Ajlan, Fahad S.
– sequence: 6
  givenname: Mari
  surname: Boesen
  middlename: E.
  fullname: Boesen, Mari E.
– sequence: 7
  givenname: Connor
  surname: McDougall
  fullname: McDougall, Connor
– sequence: 8
  givenname: Lisa
  surname: Hur
  fullname: Hur, Lisa
– sequence: 9
  givenname: Enrico
  surname: Fainardi
  fullname: Fainardi, Enrico
– sequence: 10
  givenname: Jai Jai
  surname: Shankar
  middlename: Shiva
  fullname: Shankar, Jai Jai Shiva
– sequence: 11
  givenname: Marta
  surname: Rubiera
  fullname: Rubiera, Marta
– sequence: 12
  givenname: Alexander
  surname: Khaw
  middlename: V.
  fullname: Khaw, Alexander V.
– sequence: 13
  givenname: Michael
  surname: Hill
  middlename: D.
  fullname: Hill, Michael D.
– sequence: 14
  givenname: Andrew
  surname: Demchuk
  middlename: M.
  fullname: Demchuk, Andrew M.
– sequence: 15
  givenname: Tolulope
  surname: Sajobi
  middlename: T.
  fullname: Sajobi, Tolulope T.
– sequence: 16
  givenname: Mayank
  surname: Goyal
  fullname: Goyal, Mayank
– sequence: 17
  givenname: Ting-Yim
  surname: Lee
  fullname: Lee, Ting-Yim
– sequence: 18
  givenname: Richard
  surname: Aviv
  middlename: I.
  fullname: Aviv, Richard I.
– sequence: 19
  givenname: Bijoy
  surname: Menon
  middlename: K.
  fullname: Menon, Bijoy K.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28446625$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAQhi1URLeFN0DIRy4pduw4CbdoVbpVK1rB9hw5zmRjSOxgO1T7Hn3guqT0gFA7l9HY__drNP8ROjDWAELvKTmhVNBP37ffri5Oq00Vx_yEUCGoeIVWNEt5wkVaHKAVIaxMUl6Wh-jI-x-EkJQV2Rt0mBacC5FmK3R34wHbDn-1RlkTnPQBr-04zQFavLWj3Tk59XssTfufd63wNbhu9toarA2-dtBqFbTZ4fMHMwUOGicHvIHROtfLHeCqC-CW799g7OxxNQSYBhkX2fYQbfdv0etODh7ePfZjdPPldLveJJdXZ-fr6jJRLBMiKQljigresUYoWpCCdzlICqAayVlHVd5C1nDW8iZWUWSipKzLKJCybFOi2DH6uPhOzv6awYd61F7BMEgDcbGaFmWap4xmJEo_PErnZoS2npwepdvXfy8ZBXwRKGe9d9A9SSipHwKrnwKLY14vgUXs8z-Y0kEG_ScLPbwEFwt8a-MJnf85zLfg6h7kEPrn0XsCnLE0
CitedBy_id crossref_primary_10_1002_ana_25466
crossref_primary_10_1177_02841851211035892
crossref_primary_10_1016_j_yacr_2020_05_003
crossref_primary_10_1155_2021_9933015
crossref_primary_10_1111_ene_14985
crossref_primary_10_1177_08465371211018369
crossref_primary_10_1212_CON_0000000000000839
crossref_primary_10_1212_WNL_0000000000209939
crossref_primary_10_1161_STROKEAHA_122_041241
crossref_primary_10_17116_jnevro202412412234
crossref_primary_10_1016_j_nic_2018_06_007
crossref_primary_10_1148_radiol_2019182041
crossref_primary_10_1161_STROKEAHA_123_040806
crossref_primary_10_1161_STROKEAHA_124_049013
crossref_primary_10_12677_ACM_2022_1281140
crossref_primary_10_1159_000537729
crossref_primary_10_3390_jcm10051086
crossref_primary_10_2214_AJR_21_25846
Cites_doi 10.1161/STROKEAHA.107.510768
10.1148/radiol.2503080257
10.1111/j.1552-6569.2004.tb00214.x
10.1002/ana.23546
10.1038/jcbfm.2013.203
10.1002/ana.23837
10.1038/nature03987
10.1161/STROKEAHA.114.008171
10.1016/j.acra.2012.08.013
10.1056/NEJM199512143332401
10.1056/NEJMoa1414905
10.1159/000437114
10.1016/S0140-6736(98)08020-9
10.1161/STROKEAHA.109.562116
10.1161/STROKEAHA.114.005249
10.1161/STROKEAHA.109.554386
10.3389/fneur.2013.00069
10.1136/bmj.i969
10.1148/radiol.2432060137
10.1007/s00424-005-1461-z
10.1002/ana.20782
10.1161/STROKEAHA.113.002396
10.1212/01.wnl.0000330297.58334.dd
10.1161/STROKEAHA.106.480475
10.1161/STROKEAHA.115.009250
10.1161/01.str.0000016405.06729.83
10.1161/STROKEAHA.112.660415
ContentType Journal Article
Copyright 2017 American Heart Association, Inc.
Copyright_xml – notice: 2017 American Heart Association, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/STROKEAHA.117.016616
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 1553
ExternalDocumentID 28446625
10_1161_STROKEAHA_117_016616
10.1161/STROKEAHA.117.016616
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GrantInformation_xml – fundername: CIHR
GroupedDBID ---
.XZ
.Z2
01R
0R~
123
1J1
2WC
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
C45
CS3
DIK
DIWNM
DU5
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OB3
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
ZB8
.3C
.55
.GJ
3O-
A9M
AAQQT
AAYJJ
AAYXX
ADFPA
ADGHP
ADNKB
AFFNX
AHRYX
AJNYG
BS7
CITATION
DUNZO
FW0
M18
N4W
N~M
OCUKA
ODA
ORVUJ
OUVQU
P-K
R58
T8P
X7M
YHZ
YQJ
YYP
ZGI
ZZMQN
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
YCJ
7X8
ADSXY
ID FETCH-LOGICAL-c3566-9033c164f3b6c18084f7ea1eecba43f1c7de5b43d4bbbb8856913f51e099d20c3
ISSN 0039-2499
1524-4628
IngestDate Thu Sep 04 23:44:06 EDT 2025
Thu Apr 03 07:03:12 EDT 2025
Thu Apr 24 22:58:01 EDT 2025
Tue Jul 01 03:31:50 EDT 2025
Fri May 16 03:42:52 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords blood glucose
blood pressure
creatinine
stroke
permeability
Language English
License 2017 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3566-9033c164f3b6c18084f7ea1eecba43f1c7de5b43d4bbbb8856913f51e099d20c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 28446625
PQID 1892723150
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_1892723150
pubmed_primary_28446625
crossref_primary_10_1161_STROKEAHA_117_016616
crossref_citationtrail_10_1161_STROKEAHA_117_016616
wolterskluwer_health_10_1161_STROKEAHA_117_016616
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-06-01
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: 2017-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2017
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References Lee TY (e_1_3_3_28_2) 2003; 47
e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_14_2
e_1_3_3_11_2
e_1_3_3_10_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_5_2
  doi: 10.1161/STROKEAHA.107.510768
– ident: e_1_3_3_10_2
  doi: 10.1148/radiol.2503080257
– volume: 47
  start-page: 171
  year: 2003
  ident: e_1_3_3_28_2
  article-title: CT imaging of angiogenesis.
  publication-title: Q J Nucl Med
– ident: e_1_3_3_16_2
  doi: 10.1111/j.1552-6569.2004.tb00214.x
– ident: e_1_3_3_7_2
  doi: 10.1002/ana.23546
– ident: e_1_3_3_25_2
  doi: 10.1038/jcbfm.2013.203
– ident: e_1_3_3_9_2
  doi: 10.1002/ana.23837
– ident: e_1_3_3_24_2
  doi: 10.1038/nature03987
– ident: e_1_3_3_20_2
  doi: 10.1161/STROKEAHA.114.008171
– ident: e_1_3_3_29_2
  doi: 10.1016/j.acra.2012.08.013
– ident: e_1_3_3_2_2
  doi: 10.1056/NEJM199512143332401
– ident: e_1_3_3_13_2
  doi: 10.1056/NEJMoa1414905
– ident: e_1_3_3_11_2
  doi: 10.1159/000437114
– ident: e_1_3_3_14_2
  doi: 10.1016/S0140-6736(98)08020-9
– ident: e_1_3_3_19_2
  doi: 10.1161/STROKEAHA.109.562116
– ident: e_1_3_3_21_2
  doi: 10.1161/STROKEAHA.114.005249
– ident: e_1_3_3_6_2
  doi: 10.1161/STROKEAHA.109.554386
– ident: e_1_3_3_15_2
  doi: 10.3389/fneur.2013.00069
– ident: e_1_3_3_26_2
  doi: 10.1136/bmj.i969
– ident: e_1_3_3_17_2
  doi: 10.1148/radiol.2432060137
– ident: e_1_3_3_23_2
  doi: 10.1007/s00424-005-1461-z
– ident: e_1_3_3_18_2
  doi: 10.1002/ana.20782
– ident: e_1_3_3_27_2
  doi: 10.1161/STROKEAHA.113.002396
– ident: e_1_3_3_4_2
  doi: 10.1212/01.wnl.0000330297.58334.dd
– ident: e_1_3_3_8_2
  doi: 10.1161/STROKEAHA.106.480475
– ident: e_1_3_3_12_2
  doi: 10.1161/STROKEAHA.115.009250
– ident: e_1_3_3_22_2
  doi: 10.1161/01.str.0000016405.06729.83
– ident: e_1_3_3_3_2
  doi: 10.1161/STROKEAHA.112.660415
SSID ssj0002385
Score 2.3322372
Snippet BACKGROUND AND PURPOSE—Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore...
Intracerebral hemorrhage is a feared complication of intravenous alteplase therapy in patients with acute ischemic stroke. We explore the use of multimodal...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1548
SubjectTerms Aged
Aged, 80 and over
Cerebral Hemorrhage - chemically induced
Cerebral Hemorrhage - diagnostic imaging
Cerebrovascular Circulation
Female
Fibrinolytic Agents - adverse effects
Humans
Male
Middle Aged
Prognosis
Stroke - diagnostic imaging
Stroke - drug therapy
Tissue Plasminogen Activator - adverse effects
Tomography, X-Ray Computed - methods
Title Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage After Intravenous Alteplase Therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/28446625
https://www.proquest.com/docview/1892723150
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2FIiEQQtwK4aZF4q1y8Hq9vjwGCIpALYEmUt-s9XqtljZ25Tgg8R18H9_CjHfjODQqlDxYkZNMHM_J7lzOzBDyygOXS3CVOalQ3PEl-Ckx7PuOlgEY15kWLMWM7v5BMJ75H47EUa_3q8NaWtbpQP3YWlfyP1qFc6BXrJK9gmZboXACnoN-4QgahuM_6XhmAvEHZdEwzuWi3rNTGpAfM7fdqJv8wMXzyInXVb5cWLbjpMKcTW0YBCBM6QqTyth7eF5W1TGSe4bNRPHm5W-muevwrNbnYIFr5G60_QmstXtYV-VpY8SyOHQ7QYc3EsFiQwXNxOuWIzzBZqCmZntSloVuw9XZipcRj7C5g4mdd3oj7L0btJFt-dVEestjObfVWzaywcI1A2u1WnPM_pgBSgNtF2jPd7CetruC-1EHqd3lGP2xztaOM5K2bxsBbhuH0y-fPo6G4yFmsgdgCwdsS5fuP3bPltPYeFMBS1op2Ec9MVKuketeCLYdkgY-r7vZg7lkJmzY32lLO0HK623Xsmk6XfCHbpHb30ukWCxOmwqLjp00vUvuWAeHDg1a75GeLu6TG_uWwvGA_ATQ0jKnHdDSFTjpGrQUQLvl_ImiLWjpSUHXoKUboKVr0NIGtLQDWtqCllrQPiSz96Pp27FjR4M4ioMD4sQu5wo8_ZyngWKRG_l5qCXTWqXS5zlTISwzqc8zP4VHFIkgZjwXTINDlHmu4rtkpwAMPyY0zSMhZJxKHoGUSMQ5E4F0MzCNY5Vmsk_46q4nyvbNx_EtZ8llGu8Tp_3Uuekb85f3v1wpNIEFHrN2stBwSxIWxV4IXphw--SR0XQrEWxLPwg80SdsQ_WJKaK-9BufXPEKn5Kb6z_pM7JTV0v9HAzyOn3RoPo35R3fZw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+Noncontrast+Computed+Tomography+and+Computed+Tomographic+Perfusion+in+Predicting+Intracerebral+Hemorrhage+After+Intravenous+Alteplase+Therapy&rft.jtitle=Stroke+%281970%29&rft.au=Batchelor%2C+Connor&rft.au=Pordeli%2C+Pooneh&rft.au=d%E2%80%99Esterre%2C+Christopher+D.&rft.au=Najm%2C+Mohamed&rft.date=2017-06-01&rft.issn=0039-2499&rft.eissn=1524-4628&rft.volume=48&rft.issue=6&rft.spage=1548&rft.epage=1553&rft_id=info:doi/10.1161%2FSTROKEAHA.117.016616&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_STROKEAHA_117_016616
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon